Abstracts from the 7th Joint Meeting of ABCD & UKKA 2025

Introduction and aims: Post-transplant diabetes mellitus (PTDM) causes morbidity following kidney transplantation.To reduce complications and optimise patient experience, clinicians should be proactive in managing this.Our aim was to understand the scale of this problem and to improve diabetes care.Methods and Results: Between 2011 and 2013, sixteen percent of 402 patients developed PTDM, and 9 % had a diagnosis of type 2 diabetes (T2DM).Both PTDM and T2DM had an increased risk of death (unadjusted HR 4.7, p<0.01 and HR 4.4, p<0.01, respectively).Kaplan Meier analysis showed these deaths occurred late after transplantation.A multidisciplinary (MDT) transplant-diabetes service consisting of a renal dietician, a diabetologist and a nephrologist was piloted.Fifty stable kidney transplant recipients with PTDM or T2DM were reviewed in a monthly MDT.Diabetes medication was optimised and patients triaged to a diet and lifestyle group education session, with a follow-up telephone consultation three months thereafter.Glycaemic control, body weight and patient experience data were collected.Following intervention, median HbA1c fell significantly from 65 to 58.5 mmol/mol.Fifty six percent of patients had an HbA1c improvement of 5 mmol/mol or more, whereas 34% improved by 10 mmol/mol or more.Weight significantly reduced, with 44% losing 2 kg or more.Patient experience was universally positive.Conclusions: We show a high diabetes prevalence in our kidney transplant population.We show that diabetes management can be improved, at least in the short term, through bridging the gap between specialties, in a way that patients perceive as positive.